Fertin India Profile
Key Indicators
- Authorised Capital ₹ 60.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 18.04 Cr
as on 23-10-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 25.06%
(FY 2023)
- Profit -60.00%
(FY 2023)
- Ebitda -101.14%
(FY 2023)
- Net Worth 6.96%
(FY 2023)
- Total Assets 23.01%
(FY 2023)
About Fertin India
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 60.00 Cr and a paid-up capital of Rs 18.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Fertin India Private Limited India is Priyanka Padhye as COMPANY SECRETARY. Ravi Seshadri, Michael Thomsen, and Lene Lind serve as directors at the Company.
- CIN/LLPIN
U24233GA2013FTC007857
- Company No.
007857
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
25 May 2013
- Date of AGM
07 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Fertin India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Seshadri  | Managing Director | 10-Jun-2013 | Current |
| Priyanka Padhye | Company Secretary | 10-Feb-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Michael Thomsen  | Director | 14-Dec-2017 | Current |
| Lene Lind | Director | 20-Dec-2021 | Current |
Financial Performance of Fertin India.
Fertin India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.06% increase. The company also saw a substantial fall in profitability, with a 60% decrease in profit. The company's net worth moved up by a moderate rise of 6.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fertin India?
In 2023, Fertin India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vectura Fertin Pharma Private LimitedActive 2 years 5 monthsRavi Seshadri and Michael Thomsen are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fertin India?
Fertin India has a workforce of 95 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fertin India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fertin India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
